Ocular Therapeutix Statistics
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.57-0.29 (-4.95%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ocular Therapeutix by the numbers
Ocular Therapeutix has a market capitalization of $1.23 billion based on 220.02M shares outstanding. With trailing EPS of $-1.44, Ocular Therapeutix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.6% below its 50-day average and 36.9% below its 200-day average.
Average daily trading volume is 3.03M shares, or about $16.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCUL valuation vs. peer median
| Metric | OCUL | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.23B | $1.23B | -1% |
| Avg. volume | 3.03M | 857.37K | +253% |
Peer median across 8 companies: GENB, SLN, MNKD, MLYS, AMPH, GHRS, LBRX, AVLN.
Valuation
- Market cap
- $1.23B
- Price / sales (latest FY)
- 23.59
- EPS (TTM)
- $-1.44
- Shares outstanding
- 220.02M
Price and trading
- Previous close
- 5.86
- Open
- 5.76
- Day range
- 5.54 – 5.95
- 52-week range
- 5.54 – 16.44
- 52-week change
- -54.49%
- Beta
- —
- Volume
- 2.89M
- Average volume
- 3.03M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.23B
- Forward Pe
- -3.50
- Eps
- -1.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.44
- Week52 Low
- 5.54
- Avg Volume
- 3.03M
- Shares Outstanding
- 220.02M
- Ma50
- 7.49
- Ma200
- 8.83
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -66.12%
- Pct From52w Low
- 0.54%